Of the three patients who suffered a major adverse cardiovascular event (e.g., one patient who had a heart attack with subsequent revascularization and two patients who had elective percutaneous coronary interventions), all three had no significant decrease or an increase in PAI-1, PDGF-1-beta, and ANG-1. Here, ANGPT1 is linked to myocardial infarction.